ScholarIQanswers from OpenAlex

Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy

PaperCitations, authors & open-access status

Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy have?

ScholarIQcitation count

Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy has 752 citations in the OpenAlex counts ScholarIQ stores.

When was Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy published?

ScholarIQyear

Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy has 2004 year in the ScholarIQ index.

What is the open-access status of Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy?

ScholarIQoa status

Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy has closed oa status in the ScholarIQ index.

What is the DOI of Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy?

ScholarIQdoi

The DOI for Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy is on the source record.

What is the PMID of Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy?

ScholarIQpmid

The PMID for Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy is on the source record.

What is the OpenAlex record for Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy?

ScholarIQopenalex

The OpenAlex for Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial